ReShape Lifesciences Inc. (RSLS) Reports Q2 Loss of $0.06/sh
Tweet
Share
E-mailGet Alerts RSLS Hot Sheet
Join SI Premium – FREE
ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q2 EPS of ($0.06), versus ($1.08) reported last year. Revenue for the quarter came in at $1.97 million, versus $2.25 million reported last year.
For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
